-
【Scientific Research Dynamics】Important progress in the research of Zhao Yanbing/Yang Xiangliang's research group: the radiofrequency field of bivalent gold nanoclusters activates tumor cell pyrozosis
Time of Update: 2023-02-03
On December 29, ACS Nano, a journal of the American Chemical Society, published online the research paper "Radiofrequency-Activated Pyroptosis of Bi-Valent Gold" by Professor Zhao Yanbing and Professor Yang Xiangliang, School of Life Science and Technology, Huazhong University of Science and Technology, National Engineering Research Center for Nanomedicine Nanocluster for Cancer Immunotherapy”。 Cancer immunotherapy shows great potential in killing tumor cells.
-
Science: A previously unknown, common mechanism by which cancer cells shut down the anti-cancer immune response
Time of Update: 2023-01-06
Original:Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion Douglas HanahanImage source: Ludwig Cancer Research CenterA study by the Ludwig Cancer Research Center found that a single protein was expressed in high amounts in cancer cells with multiple malignancies, establishing a multilayer barrier for the anti-cancer immune response in mouse cancer models, thereby protecting tumors from immune detection and destruction.
-
Science: A previously unknown, common mechanism by which cancer cells shut down the anti-cancer immune response
Time of Update: 2023-01-06
Original:Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion Douglas HanahanImage source: Ludwig Cancer Research CenterA study by the Ludwig Cancer Research Center found that a single protein was expressed in high amounts in cancer cells with multiple malignancies, establishing a multilayer barrier for the anti-cancer immune response in mouse cancer models, thereby protecting tumors from immune detection and destruction.
-
Screening of individuals at high risk of pancreatic cancer facilitates early diagnosis
Time of Update: 2023-01-06
Screening of individuals at high risk of pancreatic cancer is currently recommended with the aim of reducing mortality through early detection of the disease.
Screening of individuals at high risk of pancreatic cancer is currently recommended with the aim of reducing mortality through early detection of the disease.
-
Screening of individuals at high risk of pancreatic cancer facilitates early diagnosis
Time of Update: 2023-01-06
Screening of individuals at high risk of pancreatic cancer is currently recommended with the aim of reducing mortality through early detection of the disease.
Screening of individuals at high risk of pancreatic cancer is currently recommended with the aim of reducing mortality through early detection of the disease.
-
The researchers discovered a breast cancer protein that can predict chemotherapy sensitivity
Time of Update: 2023-01-05
"Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damageResearchers have identified a protein that, when present in large quantities in breast cancer tumors, is an indicator of whether DNA-damaging therapies are effective.
-
What is the efficacy and function of the old godmother? There are still some benefits
Time of Update: 2023-01-01
3, the old godmother chili sauce contains very rich vitamins, can increase the amount of rice, chili pepper also contains a special substance, can make metabolism faster, and can also promote hormone secretion, protect their skin, can control heart disease and coronary artery sclerosis disease, can reduce cholesterol, chili sauce also contains more antioxidant substances, is can prevent some chronic diseases.
-
Nature subjournal: Revealed a new mechanism of hepatic stellate cell exocryo-hexokinase HK1 to accelerate the progression of liver cancer
Time of Update: 2022-10-21
The study elucidated TGF-β-induced hepatic stellate cells (HSCs) during liver fibrosis The palmitoylation modification of hexokinase HK1 promotes the exosomement of HK1 through extracellular vesicles, while hepatoma cells hijack extracellular vesicles HK1 derived from fibrotic HSCs to enhance their own glycolytic ability and promote the proliferation of hepatoma cells.
-
The team of Professor Chen Wei from Zhejiang University published a paper in Redox Biology to reveal the toxicity mechanism of urethane, a potentially harmful substance in fermented food
Time of Update: 2022-08-15
Responsible Editor: Food Science 0 Recently, Professor Chen Wei's team from the School of Biosystems Engineering and Food Science , Zhejiang University published a research paper "Ethyl carbamate triggers ferroptosis in liver through inhibiting GSH synthesis and suppressing Nrf2" in the top international journal "Redox Biology" (IF5 12.
-
Nature's cell division study finds new cancer treatment
Time of Update: 2022-05-08
Researchers at Weill Cornell Medicine and Dana-Farber Cancer Institute report that a protein called CDC7 can actually be replaced by another protein called CDK1, which plays a role in cell division.
-
Nature sub-journal: Fitting bacteria with voice-activated switches for cancer treatment
Time of Update: 2022-04-23
DigestionRecently, Mikhail Shapiro 's team at the California Institute of Technology published a research paper entitled: Ultrasound-controllable engineered bacteria for cancer immunotherapy in the journal Nature Communications .
Mikhail Shapiro Nature Communications The research developed genetically engineered Escherichia coli to express tumor-inhibiting nanobodies and temperature-sensitive gene regulatory switches .
-
Annual Inventory Summary of Peripheral T-Cell Lymphoma Progress in 2021
Time of Update: 2022-03-09
Dehui Zou: Analysis of Clinical Characteristics and Efficacy of Peripheral T-cell LymphomaProfessor Zhang Liling at the 6th Anti-Leukemia and Lymphoma International Summit Forum with the title of "New Progress and Practice Sharing of Targeted Therapy for Peripheral T-cell Lymphoma", In-depth discussions were conducted in three aspects: "current status of peripheral T-cell lymphoma (PTCL) treatment", "optimization of initial treatment regimens", and "exploration of relapsed and refractory regimens" .
-
CStone Announces the Announcement of the Results of the Phase IV Non-Small Cell Lung Cancer Registration Clinical Study Results of Zejimay(R) (Sugelimumab Injection) in The Lancet-Oncology
Time of Update: 2022-01-23
15, 2022 /PRNewswire/ -- CStone Pharmaceuticals (SEHK: 2616), a leading biopharmaceutical company focusing on the research, development and commercialization of innovative immuno-oncology and precision medicines, today Announced that The Lancet Oncology , the world's leading clinical oncology research journal, published online a randomized trial of Zejimet® (sugalimab injection) in the first-line treatment of stage IV non-small cell lung cancer (NSCLC).
-
Eur J Cancer: In HER2-positive early operable breast cancer patients, the efficacy and predictive markers of trastuzumab combined with everolimus before surgery
Time of Update: 2021-12-03
The clinical remission rates of trastuzumab (T) and trastuzumab combined with everolimus (T+E) groups were 34.
The clinical remission rates of trastuzumab (T) and trastuzumab combined with everolimus (T+E) groups were 34.
The clinical remission rates of trastuzumab (T) and trastuzumab combined with everolimus (T+E) groups were 34.
-
Alzheimers & Dementia: Investigating the relationship between cancer and dementia risk
Time of Update: 2021-11-13
found in a large prospective community cohort study that cancer has been determined by several epidemiological studies to have a protective effect on dementia, especially Alzheimer’s disease (AD) .
